Pharma III – Pharmaceutical and Biotech Regulation

Course content

The course will give the participants knowledge on how to move research towards a commercial setting by connecting and learning from industry players, biotech, and start-ups from the Danish innovation ecosytem. The course will also provide insights on how to secure IP, legals and financing in the early phases. The course will provide insights on critical issues for translating research into either products or start-ups, and on decision processes for progressing research either in industry or start-ups.

The course will include lectures, site visits and discussions with key industry players from both speciality pharma companies (for instance Novo Nordisk, Lundbeck), biotech companies (for instance Genmab, Symphogen, Orphazyme) and start-ups primarily from BioInnovation Institute and COBIS.


BRIDGE - Translational Excellence Programme


Learning outcome

Upon completing the course, participants should be able to:



  • Understand how the organizational set-up supports how projects are prioritized in pharmaceutical and biotech companies
  • Understand the rationale behind key business processes in the pharmaceutical and biotech industry - and how to move research from academia into start-ups or existing companies.



  • Describe how a pharmaceutical company is organized to secure optimal decision processes between research and development (R&D) and commercial units
  • Describe the IP, legal and financial processes behind building a start-up based on translational research.



  • Explain the rationale behind a project management portfolio, including how companies decide from a pool of competing projects to create a profitable portfolio that achieve the company’s strategic goals
  • Discuss and understand commercial decision structures in pharmaceutical  and biotech companies and start-ups
  • Discuss and understand potential factors influencing the IP, legal and financing processes from research lab to start-up company or license agreement with an established company


Site visits, lectures and discussions.

Course literature is published on Absalon.

Participants must meet the admission criteria in BRIDGE - Translational Excellence Programme.

Continuous feedback during the course
Type of assessment
Continuous assessment
Course participation
Type of assessment details
Attendance and active participation.
All aids allowed
Marking scale
passed/not passed
Censorship form
No external censorship
Criteria for exam assessment

Active contribution and course participation according to the BRIDGE Guidelines.

Part time Master and Diploma courses

  • Category
  • Hours
  • Lectures
  • 2
  • Preparation
  • 4
  • Excursions
  • 15
  • English
  • 21


Course number
Programme level
Part Time Master
See course dates and course programme in Absalon.

*This course is offered in spring 2024 for BRIDGE 2022-2024.
15 participants
Study Board for the Professionel Master´s Degree Programmes at The Faculty og Health and Medical Science
Contracting department
  • Department of Biomedical Sciences
Contracting faculty
  • Faculty of Health and Medical Sciences
Course Coordinator
  • Trine Winterø   (6-77756c7a6c714376787167316e7831676e)
Saved on the 04-03-2023

Are you BA- or KA-student?

Are you bachelor- or kandidat-student, then find the course in the course catalog for students:

Courseinformation of students